Physitrack PLC (“Physitrack” or the “Company”) announces that, further to the share buy-back programme announced on 21 July 2026 and commenced on 10 August 2026, it has repurchased the following shares under the programme during the week of 12 to 16 October 2026.
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 12 - 16 October 2026 | 6,500 | SEK 11.1190 | SEK 72,273.80 | 61,237 | 16,260,766 | 0.3766% |
Individual transactions
| Date | Quantity | Average price (SEK) |
| 2026-10-12 | 500 | 9.70 |
| 2026-10-13 | 1,500 | 11.45 |
| 2026-10-14 | 1,500 | 11.45 |
| 2026-10-15 | 1,500 | 10.90 |
| 2026-10-16 | 1,500 | 11.1492 |
Purpose and safe harbour
The transactions above were carried out under the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052. The purpose of the buy-back programme is to meet the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| Field | Detail |
| 1. Issuer | Physitrack PLC; LEI 213800PC4QYNWHPCP774 |
| 2. Instrument / ISIN | Ordinary shares / GB00BYX22590 |
| 3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency | SEK |
| 5. Purpose | To meet the Company's obligations under its employee share plans, permitted under Article 5(2) MAR |
| 6. Executing broker | Pareto Securities, non-discretionary mandate |
This disclosure is made in accordance with Article 5(3) of MAR and Commission Delegated Regulation (EU) 2016/1052.